Cefditoren

Basic Information

Item Value
DrugBank ID DB01066
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 osteoarthritis susceptibility KG + DL
2 rheumatoid arthritis KG + DL
3 osteoarthritis KG + DL
4 hemoglobinopathy KG + DL
5 brachyolmia KG + DL
6 colobomatous microphthalmia-rhizomelic dysplasia syndrome KG + DL
7 acromesomelic dysplasia, Hunter-Thompson type KG + DL
8 brachyolmia-amelogenesis imperfecta syndrome KG + DL
9 myosclerosis KG + DL
10 partial deletion of the short arm of chromosome 16 KG + DL
11 beta-thalassemia with other manifestations KG + DL
12 pseudoachondroplasia KG + DL
13 female breast carcinoma KG + DL
14 brachydactyly-syndactyly syndrome KG + DL
15 arthropathy KG + DL
16 gout KG + DL
17 hemolytic anemia due to glucophosphate isomerase deficiency KG + DL
18 antithrombin deficiency type 2 KG + DL
19 pyropoikilocytosis, hereditary KG + DL
20 pyruvate kinase deficiency of red cells KG + DL
21 factor 5 excess with spontaneous thrombosis KG + DL
22 heparin cofactor 2 deficiency KG + DL
23 congestive heart failure KG + DL
24 myocardial infarction KG + DL
25 alopecia KG + DL
26 acute pulmonary heart disease KG + DL
27 peripheral vascular disease KG + DL
28 thrombophilia KG + DL
29 congenital hypotrichosis milia KG + DL
30 hypotrichosis simplex of the scalp KG + DL
31 breast fibrocystic disease KG + DL
32 diffuse alopecia areata KG + DL
33 benign prostatic hyperplasia (disease) KG + DL
34 idiopathic granulomatous myositis KG + DL
35 myositis fibrosa KG + DL
36 tendinitis KG + DL
37 pulmonary hypertension KG + DL
38 septal myocardial infarction KG + DL
39 posterolateral myocardial infarction KG + DL
40 posteroinferior myocardial infarction KG + DL
41 fibromyalgia KG + DL
42 myocardial infarction (disease) KG + DL
43 chronic pulmonary heart disease KG + DL
44 intermittent vascular claudication KG + DL
45 toxocariasis KG + DL
46 peripheral arterial disease KG + DL
47 coronary stenosis KG + DL
48 migraine disorder KG + DL
49 kyphoscoliotic heart disease KG + DL
50 Lyme disease KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.